Original Article

Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages

Correspondence to: Urs P. Steinbrecher

Lysophosphatidylcholine (lysoPC) is a bioactive phospholipid that is involved in atherogenesis and inflammatory processes. However, the present understanding of mechanisms whereby lysophosphatidylcholine exerts its pathophysiological actions is incomplete. In the present work, we show that lysoPC stimulates phospholipase D (PLD) activity in mouse peritoneal macrophages. PLD activation leads to the generation of important second messengers such as phosphatidic acid, lysophosphatidic acid, and diacylglycerol, all of which can regulate cellular responses involved in atherogenesis and inflammation. The activation of PLD by lysoPC was attenuated by down-regulation of protein kinase C activity with prolonged incubation with 100 nM of 4ß-phorbol 12-myristate 13-acetate (PMA). Preincubation of the macrophages with the tyrosine kinase inhibitor genistein also decreased the stimulation of PLD by lysoPC, while pretreatment with orthovanadate, which inhibits tyrosine phosphatases, enhanced basal and lysoPC-stimulated PLD activity. The activation of PLD by lysoPC was attenuated by the platelet activating factor (PAF) receptor antagonist WEB-2086, suggesting a role for PAF receptor activation in this process. Furthermore, acetylation of lysoPC substantially increased its potency in activating PLD, suggesting that a cellular metabolite of lysoPC such as 1-acyl 2-acetyl PC might be responsible for at least part of the effect of lysoPC on PLD.—Gómez-Muñoz, A., L. O'Brien, R. Hundal, and U. P. Steinbrecher. Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. J. Lipid Res. 1999. 40: 988–993.

Supplementary key words: lysophosphatidylcholine, phospholipase D, protein kinase C, macrophages

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. A. Farooqui and L. A. Horrocks Phospholipase A2-Generated Lipid Mediators in the Brain: The Good, the Bad, and the Ugly Neuroscientist, June 1, 2006; 12(3): 245 - 260. [Abstract] [PDF]

				L. Brizuela, M. Rabano, A. Pena, P. Gangoiti, J. M. Macarulla, M. Trueba, and A. Gomez-Munoz Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion J. Lipid Res., June 1, 2006; 47(6): 1238 - 1249. [Abstract] [Full Text] [PDF]

				T. Q. Nhan, W. C. Liles, and S. M. Schwartz Role of Caspases in Death and Survival of the Plaque Macrophage Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 895 - 903. [Abstract] [Full Text] [PDF]

				E. Perez-Andres, M. Fernandez-Rodriguez, M. Gonzalez, A. Zubiaga, A. Vallejo, I. Garcia, C. Matute, S. Pochet, J. P. Dehaye, M. Trueba, et al. Activation of phospholipase D-2 by P2X7 agonists in rat submandibular gland acini J. Lipid Res., August 1, 2002; 43(8): 1244 - 1255. [Abstract] [Full Text] [PDF]

				G. K. Marathe, A. R. Silva, H. C. de Castro Faria Neto, L. W. Tjoelker, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids J. Lipid Res., September 1, 2001; 42(9): 1430 - 1437. [Abstract] [Full Text] [PDF]

				S. B. Ryu and J. P. Palta Specific inhibition of rat brain phospholipase D by lysophospholipids J. Lipid Res., June 1, 2000; 41(6): 940 - 944. [Abstract] [Full Text]

				A. Gomez-Munoz, J. S. Martens, and U. P. Steinbrecher Stimulation of Phospholipase D Activity by Oxidized LDL in Mouse Peritoneal Macrophages Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 135 - 143. [Abstract] [Full Text] [PDF]

				K. Zhu, L. M. Baudhuin, G. Hong, F. S. Williams, K. L. Cristina, J. H. S. Kabarowski, O. N. Witte, and Y. Xu Sphingosylphosphorylcholine and Lysophosphatidylcholine Are Ligands for the G Protein-coupled Receptor GPR4 J. Biol. Chem., October 26, 2001; 276(44): 41325 - 41335. [Abstract] [Full Text] [PDF]